Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism

By N. Kucher, P. Boekstegers, O. Müller, C. Kupatt, J. Beyer-Westendorf, T. Heitzer, U. Tebbe, J. Horstkotte, R. Müller, E. Blessing and 9 more. Circulation, 2014

958 citations recorded by the source corpus.

Subfields: Critical Care and Intensive Care Medicine, Internal Medicine, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/15a6cb5cd7d5adbecde6deb168bb2b91778183be

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Internal Medicine

In Pulmonary and Respiratory Medicine

N. Galiè

Citations in the corpus

[2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism]. (2014, positive): “hours—significantly reduced the subannular RV/LV dimension ratio between baseline and 24-hour follow-up without an increase in bleeding complications.(336)”
Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. (2012, background): “(Table 14, e-Table 15) and that systemic thrombolysis increases bleeding in patients with acute PE,(143,147) and low-quality evidence that CDT can accelerate breakdown of acute PE.(154) This evidence has indirect bearing on thrombolysis in patients with UEDVT, but it has not changed the overall qual”
ESC Guidelines on the diagnosis and management of acute pulmonary embolism (2014, background): “hours—significantly reduced the subannular RV/LV dimension ratio between baseline and 24-hour follow-up without an increase in bleeding complications.(336)”
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) (2019, background): “In that study, ultrasoundassisted thrombolysis was associated with a larger decrease in the RV/LV diameter ratio at 24 h, without an increased risk of bleeding.(293) Data from two prospective cohort studies(294,295) and a registry,(296) with a total of 352 patients, support the improvement in RV fun”